Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2017.389 | A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) – SELECT – PsA 1 | Prof. TAM Lai Shan |
| 2017.239 | The Hong Kong Psoriatic Arthritis Screening program | Prof. TAM Lai Shan |
| 2020.128 | Portable integrated diagnostic platform for chronic auto-immune diseases |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.401 | Immunological role of the ILC2-B lymphocyte regulatory axis in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.264 | Incidence of and associated factors of infective complications in rheumatology patients taking DMARDs | Dr. TAM Lai Shan |
| 2017.605 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus | Prof. TAM Lai Shan |
| 2019.247 | Survival benefit of statin use in patients with immune mediated inflammatory diseases in Hong Kong - A population-based study | Prof. TAM Lai Shan |
| 2020.129 | Vascular effects of achieving low disease activity in axial spondyloarthritis - a 2-year prospective cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2018.225 | The APLAR Spondyloarthritis (SpA) Registry |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.141 | Quantification of erosion, joint space width and new bone formation using deep learning-based approaches |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.063 | Effects of tight-control strategy with rosuvastatin on progression of subclinical carotid and coronary atherosclerosis in psoriatic arthritis- a prospective cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.180 | The microbiome study in psoriasis and psoriatic arthropathy patients in Hong Kong |
Prof. TAM Lai Shan 譚麗珊 |
| 2018.144 | Bone Microarchitecture Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced osteoporosis |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.633 | An exploratory maintenance trial evaluating the effect of BI 655064 in Lupus Nephritis patients who have achieved a meaningful response either at the end of 1293.10 or after an induction treatment outside of 1293.10 |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2019.224 | Effects of achieving SDAI remission on joint space outcomes progression in early rheumatoid arthritis: an HR-pQCT study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.540 | A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). |
Dr. TAM Lai Shan 譚麗珊 |
| 2017.700 | Circulating microRNA 99b as biomarker for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.573 | Subclinical gut inflammation and gut microbiome in axial spondyloarthritis patients in Hong Kong |
Prof. TAM Lai Shan 譚麗珊 |
| 2018.417 | Prevention of metacarpophalangeal joints structure damage in patients with psoriatic arthritis using tofacitinib | Prof. TAM Lai Shan |
| 2017.683 | Calprotectin in psoriatic arthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.650 | Effects of tight-control strategy with and without rosuvastatin on progression of subclinical coronary and carotid atherosclerosis in psoriatic arthritis- a randomized placebo-controlled study |
Prof. TAM Lai Shan 譚麗珊 |
| 2010.191 | Human Papillomavirus infection and cervical intraepithelial neoplasia in patients with systemic lupus erythematosus- the role of toll-like receptors | Prof. TAM Lai Shan |
| 2011.509 | In vivo assessment of periaricular and generalized bone loss in patients with rheumatoid arthritis by high resolution peripheral quantitative computed tomography | Prof. Tam Lai Shan |
| 2010.455 | A prospective case-control cost of illness studies in systemic lupus erythematosus | Prof. Tam Lai Shan |
| 2011.228 | Effects of inflammation on bone loss in rheumatoid arthritis: Does inflammation affect joints and bone equally? | Prof. Tam Lai Shan |
| 2011.570 | Bone quality in men with rheumatoid arthritis: A case-control study using the high-resolution peripheral quantitative computed tomography | Prof. TAM Lai Shan |
| 2012.478 | Vascular effects of achieving minimal disease activity iin psoriatic arthritis - a 2 year prospetive cohort study | Prof. TAM Lai Shan |
| 2008.475 | Innate pathogen recognition in systemic lupus erythematosus: Toll-like receptors and NOD-like receptors | Prof Tam Lai Shan |
| 2009.583 | Function and expression profile of the nucleotide-blinding and oligoerization domain (NOD)-2 receptors in systemic lupus erythematosus | Prof. Tam Lai Shan |
| 2009.215 | In vivo assessment of bone microarchitecture in patients on chronic steroid therapy by high-resolution peripheral quantitative computed tomography and the finite method | Prof. Tam Lai Shan |
| 2010.250 | HMGB1: a danger signal molecule of the innate immune response for the immunopathogenesis of systemic lupus erythematosus | Prof. TAM Lai Shan |
| 2011.547 | The role of Receptor for Advanced Glycation End Products (RAGE) in the pathogenesis of systemic Lupus erythematosus (SLE) | Professor TAM Lai Shan |
| 2009.273 | Diagnostic and Prognostic Values of Anti-Ceclic Citullinated Peptide Antibodies in Chinese Population with Rheumatoid Arthritis | Prof. Tam Lai Shan |
| 2011.031 | The role of HMGB1 in the pathogenesis of systemic lupus erythematosus | Professor TAM Lai Shan |
| 2011.174 | A stochastic cost-effectiveness analysis of an early inflammatory arthritis clinic in Hong Kong | Prof. TAM Lai Shan |
| 2025.008 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants with Active Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2025.264 | Identifying the optimal erosion volume threshold for predicting rheumatoid arthritis in individuals with arthralgia: a high-resolution peripheral quantitative computed tomography study | Prof. TAM Lai Shan |
| 2025.258 | Developing neural network based new methods for the detection and quantification of enthesiophytes and erosions in inflammatory arthritis diagnosis using high resolution peripheral quantitative computed tomography (HR-pQCT) images | Prof. TAM Lai Shan |
| 2025.358 | Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study | Prof. TAM Lai Shan |
| 2024.718 | REMIPPSA: REMISSION STATUS IN PSORIATIC ARTHRITIS FROM THE PATIENT’S PERSPECTIVE. A QUALITATIVE STUDY. | Prof. TAM Lai Shan |
| 2025.432 | The First Phase Study to Evaluate the Safety of In-Vivo CAR-T Therapy for Patients with Refractory Systemic Lupus Erythematosus | Prof. Tam Lai Shan |
| 2024.661 | Methotrexate versus TNF inhibition in preventing structural damage in Early Psoriatic Arthritis: A randomized trial using HR-pQCT (MeTEPsA trial) | Prof. TAM Lai Shan |
| 2023.633 | Defining active and structural lesions in the sacroiliac joint and spine by MRI and their predictive utility in axial psoriatic arthritis -a prospective study | Prof Tam Lai Shan |
| 2025.247 | Arresting Enthesiophyte and Erosion Progression in PsA: A 5-Year HR-pQCT Study | Prof. TAM Lai Shan |
| 2025.019 | Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naïve Participants with Active Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2025.244 | AI-Powered Decision-Making Model in Optimizing Belimumab and Telitacicept Treatment for SLE through Genetic and Immune Profiling |
Prof. TAM Lai Shan 譚麗珊 |
| 2025.866 | Erosion and joint space trajectories assessed using HR-pQCT in RA correlation with functional outcomes | Prof. TAM Lai Shan |
| 2024.221 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.352 | A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout |
Prof. TAM Lai Shan 譚麗珊 |
| 2025.738 | Cardiovascular and neurocognitive benefit of disease modifying antirheumatic drugs in patients with rheumatoid arthritis and psoriatic arthritis in Hong Kong: A large population study | Prof. TAM Lai Shan |
Page 218 of 289.